These drugs, which are among the most common types of blood thinners, can interfere with traditional coagulation tests, producing unreliable results.

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The “Elecsys pTau181 test” measures pTau181 protein levels in human plasma which ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Scientists have grown a human embryo-like structure in a lab which replicates very early human development - including the production of blood stem cells. The lab-grown embryo model could help ...

Standard lipid panels don't always cover underlying markers that might be affecting your cardiovascular health. Dr Jeremy London shares 3 advanced lab tests. Most people rely on a standard lipid panel ...

A new blood test can diagnose chronic fatigue syndrome, also known as CFS or ME, with an accuracy of 96%, according to scientists who developed it. The researchers, from the University of East Anglia, ...

Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Whoop has officially announced that Advanced Labs, its service that integrates blood biomarker testing directly into the platform, is now live in the United States. When we first analyzed the service ...